Detalhe da pesquisa
1.
Ibrutinib as part of risk-stratified treatment for post-transplant lymphoproliferative disorder: The phase 2 TIDaL trial.
Blood
; 2024 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643491
2.
The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.
Br J Haematol
; 188(6): 918-923, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31682002
3.
Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post-BCR inhibitor setting: a UK wide analysis.
Br J Haematol
; 185(4): 656-669, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30768675
4.
Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting.
Br J Haematol
; 179(3): 471-479, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28857136
5.
An unexpected cause of iron deficiency.
Gut
; 2020 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32546471
6.
Central nervous system plasmablastic lymphoma evolving from polyclonal plasmacytosis.
Br J Haematol
; 183(3): 345, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29984820
7.
Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma.
Br J Haematol
; 181(4): 555-559, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28342183
8.
Lenalidomide can be highly effective in chronic lymphocytic leukaemia despite T-cell depletion and deletion of chromosome 17p.
Eur J Haematol
; 87(4): 372-5, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21679253
9.
A rare cause of weight loss.
Gut
; 63(6): 1024, 1027, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24277727
10.
Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents.
Blood Adv
; 4(16): 3977-3989, 2020 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32841336
11.
Role of MYC and BCL2 expression in a cohort of 43 patients with DLBCL: a retrospective study.
J Clin Pathol
; 74(12): 816-818, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33380460
12.
The development of sarcoidosis with the use of alemtuzumab - clues to T-cell immune reconstitution.
Br J Haematol
; 138(4): 559-60, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17587337